semaglutide cardiovascular outcomes trial Oral and in Patients with Type 2 Diabetes Randomized clinical trials with cardiovascular

Semaglutide trials report discontinuation rates of approximately 5-7% due to adverse events

Cutting-Edge Automation CUREX utilizes advanced automation in drug development, enhancing speed and accuracy in bioanalytical testing

For help choosing an app for the full duration of GLP-1 treatment, this guide covers what to look for

Simon TG (2025)

However, relying solely on Ozempic without a well-balanced diet can limit its effectiveness and may lead to nutritional deficiencies

The proportion of patients achieving an HbA1C below 7% was also higher in the treatment group as compared to the control group at every time point ( Figure 2 )